Novo Nordisk A/S ADR buy The Goldman Sachs Group, Inc.
Start price
22.01.26
/
50%
€53.00
Target price
22.01.27
-
Performance (%)
-21.23%
Price
22:26
€41.75
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -21.23%. This prediction currently runs until 22.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novo Nordisk A/S ADR | 1.091% |
| iShares Core DAX® | -0.821% |
| iShares Nasdaq 100 | -1.743% |
| iShares Nikkei 225® | 1.215% |
| iShares S&P 500 | -1.167% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for NVO provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.70
28.11.25
28.11.25
€46.61
28.11.26
28.11.26
-2.22%
22:26
22:26
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€123.00
30.05.24
30.05.24
€144.02
30.05.25
30.05.25
-49.11%
31.05.25
31.05.25